Shopping Cart
Remove All
Your shopping cart is currently empty
HedgehogIN-6 (Compound Q29) is a Hedgehog (Hh) inhibitor utilized in cancer research. It inhibits the hedgehog (Hh) pathway by binding to the cysteine-rich domain (CRD) of Smoothened (Smo) and blocking its cholesterol modification.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | HedgehogIN-6 (Compound Q29) is a Hedgehog (Hh) inhibitor utilized in cancer research. It inhibits the hedgehog (Hh) pathway by binding to the cysteine-rich domain (CRD) of Smoothened (Smo) and blocking its cholesterol modification. |
| In vitro | Q29 (1-10 μM; 24 hours) inhibits GLI1 protein expression activated by Shh-N in a dose-dependent manner. Q29 (1-10 μM; 24 + 12 hours) also suppresses Hh signal-dependent cell proliferation in a dose-dependent way. Under varying concentrations of Shh-N, Q29 inhibits Gli-luciferase activity, with an IC50 of 1.33 μM. |
| In vivo | When administered orally via gavage at a dose of Q29 (90 mg/kg; twice daily for 13 days), it effectively inhibits tumor growth in Ptch1+/P53/ mice. |
| Molecular Weight | 389.61 |
| Formula | C25H43NO2 |
| Cas No. | 2916444-33-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.